Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy
Authors
Yao Lu (ORCID: https://orcid.org/0000-0001-8511-3642)
Jing Li (ORCID: https://orcid.org/0000-0002-2052-9302)
David H. Hsi (ORCID: https://orcid.org/0000-0002-0914-8947)
Wenxia Li (ORCID: https://orcid.org/0009-0001-8663-6397)
Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy
Yao Lu, Jing Li, David H. Hsi, Wenxia Li et al.
Journal
Heart
Topics
Cardiomyopathy and Myosin Studies
article
Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy
Yao Lu, Jing Li, David H. Hsi, Wenxia Li, Yundi Jiao, H.C. Wang, Liansheng Chang, Shengjun Ta, Liwen Liu, Bo Shan, Bo Wang, Changhui Lei, Xumei Ou, Jing Wang
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy — Yao Lu, Jing Li, et al. · Heart (2025) | TGRS Research Map | TGRS